NeoGenomics, Inc. Acquisitions, Net of Cash Acquired
NeoGenomics, Inc. (NEO) reported Acquisitions, Net of Cash Acquired of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-07-28
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $463.00K.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $6.45M.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
- NeoGenomics, Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $463.00K derived: sum of 2 quarters · filed 2026-02-17 | $6.45M 10-K · filed 2026-02-17 | ||
| 2025-09-30 | $463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $6.45M 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | $5.99M 10-Q · filed 2026-07-28 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-29 | ||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $419.40M derived: sum of 3 quarters · filed 2024-02-20 | $419.40M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $419.40M derived: sum of 2 quarters · filed 2022-11-08 | $419.40M 10-Q · filed 2022-11-08 | $419.40M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-06-30 | $419.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $419.40M 10-Q · filed 2022-08-09 | $419.40M derived: sum of 3 quarters · filed 2023-02-24 | $419.40M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $0.00 derived: sum of 4 quarters · filed 2023-02-24 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $37.00M 10-K · filed 2023-02-24 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $37.00M 10-Q · filed 2021-11-04 | $37.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $37.00M 10-Q · filed 2021-08-09 | $37.00M derived: sum of 3 quarters · filed 2022-02-25 | $37.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $37.00M 10-Q · filed 2021-05-06 | $37.00M derived: sum of 2 quarters · filed 2022-02-25 | $37.00M derived: sum of 3 quarters · filed 2022-02-25 | $37.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | -$399.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $0.00 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-04-29 | ||||
| 2018-12-31 | $125.38M 10-K · filed 2021-02-25 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 | ||||
| 2016-12-31 | -$1.03M 10-K · filed 2019-02-26 | ||||
| 2015-12-31 | $72.94M 10-K · filed 2018-03-13 | ||||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $5.83M 10-K · filed 2017-03-14 | |||
| 2014-09-30 | $5.83M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |